Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Infant formula price-fixing

This article was originally published in The Tan Sheet

Executive Summary

Divided U.S. Supreme Court leaves intact the dismissal of a class action lawsuit against Abbott Labs and Bristol-Myers Squibb. Louisiana residents who purchased the companies' infant formulas between January 1980 and December 1992 argued their lawsuit properly belonged in state court, rather than federal court. In June 1999, a New Orleans federal appeals court affirmed dismissal of the lawsuit for failure to state a claim under Louisiana antitrust law. The U.S. Supreme Court heard oral arguments on March 27 (1"The Tan Sheet" March 20, p. 8). However, the justices split 4-4, with Justice Sandra Day O'Connor not participating in the case
Advertisement

Related Content

Federal Jurisdiction Of Formula Price-Fixing Suit Appropriate - Companies
Federal Jurisdiction Of Formula Price-Fixing Suit Appropriate - Companies

Topics

Advertisement
UsernamePublicRestriction

Register

PS091064

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel